These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1711678)

  • 21. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
    Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus.
    Palladino DE; Hopkins JL; Ingraham RH; Warren TC; Kapadia SR; Van Moffaert GJ; Grob PM; Stevenson JM; Cohen KA
    J Chromatogr A; 1994 Jul; 676(1):99-112. PubMed ID: 7522840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic analysis of the catalysis of strand transfer from internal regions of heteropolymeric RNA templates by human immunodeficiency virus reverse transcriptase.
    DeStefano JJ
    J Mol Biol; 1994 Nov; 243(4):558-67. PubMed ID: 7525968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the reverse transcriptase of human immunodeficiency virus type 1 by dNTPs.
    West AB; Roberts TM; Kolodner RD
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9720-4. PubMed ID: 1384060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.
    Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E
    J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.
    Boyer JC; Bebenek K; Kunkel TA
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6919-23. PubMed ID: 1379727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
    Debyser Z; De Vreese K; Knops-Gerrits PP; Baekelandt V; Bhikhabhai R; Strandberg B; Pauwels R; Anné J; Desmyter J; De Clercq E
    Mol Pharmacol; 1993 Apr; 43(4):521-6. PubMed ID: 7682649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor.
    Olsen DB; Carroll SS; Culberson JC; Shafer JA; Kuo LC
    Nucleic Acids Res; 1994 Apr; 22(8):1437-43. PubMed ID: 7514786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.
    Loya S; Rudi A; Kashman Y; Hizi A
    Biochem J; 2002 Mar; 362(Pt 3):685-92. PubMed ID: 11879196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.
    Evans DB; Kézdy FJ; Tarpley G; Sharma SK
    Biotechnol Appl Biochem; 1993 Feb; 17(1):91-102. PubMed ID: 7679907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance.
    Vaccaro JA; Anderson KS
    Biochemistry; 1998 Oct; 37(40):14189-94. PubMed ID: 9760256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
    Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
    J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
    Ji X; Klarmann GJ; Preston BD
    Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
    Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
    Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.
    Rittinger K; Divita G; Goody RS
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8046-9. PubMed ID: 7544013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis.
    Kaushik N; Harris D; Rege N; Modak MJ; Yadav PN; Pandey VN
    Biochemistry; 1997 Nov; 36(47):14430-8. PubMed ID: 9398161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
    Smerdon SJ; Jäger J; Wang J; Kohlstaedt LA; Chirino AJ; Friedman JM; Rice PA; Steitz TA
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3911-5. PubMed ID: 7513427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.